News
All News
Publications
All PublicationsPharmTechPharmTech Europe
Multimedia
All VideosAsk the ExpertBehind The HeadlinesDrug Digest VideosDrug Solutions Podcast
Conferences
Conference CoverageConference Listing
More
Webcasts
Resources
ICH Q9 Revision: A Comprehensive Resource on Quality Risk ManagementPeer-Reviewed ResearchPharmTech ProductsPharma InsightsSponsored PodcastsSponsored VideosSponsored eBooksWhitepapers

Subscribe

  • News
  • Publications
  • Multimedia
  • Conferences
  • Webcasts
  • Resources
  • Subscribe
  • Analytics
    • Bio/Pharmaceutical Analysis Techniques
    • Laboratory Equipment and Instruments
  • Data and Artificial Intelligence
  • Dosage Forms
    • Solid/Semi-Solid Dosage
    • Specialty Dosage Drugs
    • Parenterals and Injectables
    • Inhalation Drugs
  • Drug Development
    • Intellectual Property and Patents
    • Process and Scaling
    • APIs and Excipients
    • Ingredients
    • Formulation and Drug Delivery
  • Manufacturing
    • Aseptic/Sterile Processing
    • Equipment
    • Process and Automation
    • Manufacturing, Parenterals and Injectables
    • Manufacturing, Biosimilars and Biobetters
    • Manufacturing, Inhalation Drugs
    • Manufacturing, Solid and Semi-Solid Dosage Drugs
    • Manufacturing, Cell Therapies
    • Manufacturing, Biologic Drugs
    • Supply Chain
    • Manufacturing, Gene Therapies
    • Packaging and Distribution
  • Outsourcing
    • Contract Research Services
    • Contract Analytical Services
    • Contract Development Services
    • Regulatory Consulting
    • Logistics and Distribution
    • Contract Manufacturing Services
  • Quality Systems
    • Ask the Expert
    • Quality Assurance/Quality Control
    • Regulatory Oversight and Compliance
Spotlight -
Analytics|
Dosage Forms|
Drug Development|
Manufacturing|
Outsourcing|
Quality Systems
Advertisement

Dr Julie Suman, Vice President Scientific Affairs, Aptar Pharma

Advertisement

Articles by Dr Julie Suman, Vice President Scientific Affairs, Aptar Pharma

Using intranasal delivery for drug repositioning: a compelling proposition for lifecycle management.

ByDr Julie Suman, Vice President Scientific Affairs, Aptar Pharma,Reenal Gandhi, Business Development, Aptar Pharma
May 1st 2023
Advertisement

Latest Updated Articles



    Advertisement
    Advertisement

    Trending on Pharmaceutical Technology

    1

    PharmTech Weekly News Roundup – Week of November 3, 2025

    2

    New Dosage Forms and Delivery Systems Driving 505(b)(2) Success

    3

    AAPS PharmSci 360: Enhancing Bioanalysis with AI and Other Technologies

    4

    How AI, Machine Learning, and Large Language Models Enhance Bioanalysis

    5

    2025 AAPS PharmSci 360 to Highlight Next-Gen AI for Drug Development

    • About Us
    • Advertise
    • Contact Us
    • Editorial Info
    • Editorial Advisory Board
    • Do Not Sell My Personal Information
    • Privacy Policy
    • Terms and Conditions
    Contact Info

    259 Prospect Plains Rd, Bldg H
    Cranbury, NJ 08512

    609-716-7777

    Brand Logo

    © 2025 MJH Life Sciences®

    All rights reserved.

    Home
    About Us
    News
    Contact Us